AXIM Biotechnologies's total assets for Q1 2025 were $3.35M, a decrease of -2.94% from the previous quarter. AXIM total liabilities were $13.98M for the fiscal quarter, a 0.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.